Innovative Diagnostic Development Diagnostic Solutions Laboratory has developed over 500 assays and is actively engaged in creating critical tests for COVID-19, positioning it as a leader in rapid diagnostic innovation. This extensive experience indicates a strong capacity for expanding testing services and developing new assay platforms to meet emerging healthcare needs.
Market Penetration Potential With annual revenues between $50M and $100M and an operational focus on clinical diagnostics, there is significant growth opportunity in expanding market share within biotech and clinical laboratory sectors, particularly by leveraging their recent COVID-19 testing capabilities.
Leadership Expertise Led by industry veterans with over two decades of medical and scientific leadership, the company’s executive team can foster strategic partnerships, attract new clients, and build credibility in the healthcare diagnostics space, opening avenues for business development initiatives.
Technology Stack Leverage Utilizing modern digital infrastructure such as Drupal, CDN services, and robust security protocols like reCAPTCHA and HSTS, the company is well-positioned to enhance its online presence and customer engagement, facilitating sales and client onboarding through digital channels.
Growth in Healthcare Demand Given the rising demand for accurate and timely diagnostic testing driven by global health crises, Diagnostic Solutions Laboratory is poised to capitalize on emerging opportunities in infectious disease testing, including expansion into new COVID-19 variants or other infectious disease assays.